These five stocks can give you a tremendous return of more than 70 percent! Brokerage firm gave 'BUY' rating

News Topical, Digital Desk : Stocks To Buy: It is said about the stock market that it is completely a game of possibilities. Today we are going to tell you about those five stocks which can give you a tremendous return of more than 70 percent. The brokerage firm has advised to buy them. Let us tell you which stocks are included in this list and what has been said by the brokerage firm regarding this.

1- Samhi Hotels

There is a possibility of tremendous growth in the stock of Samhi Hotels. It has thirty-two properties and four thousand nine hundred and forty-eight rooms in fourteen cities of India. It is estimated that by the financial year 2029, there will be more than 5500 rooms. It has recently entered into a partnership of 752 crores with GIC. Brokerage firm Ventura Securities has advised to buy the stock of Samhi Hotels at a target price of 391.

2-Aditya Birla Lifestyle Brands

Aditya Birla Lifestyle Brands stock is expected to rise by about twenty percent. This company was listed on the stock exchange after separating from Aditya Birla Fashion Retail. Brokerage firm Anand Rathi Shares and Stock Brokers says that it has started covering this stock with a target price of Rs 186. 

3-Ajax Engineering

Ajax Engineering is one of the world's leading self-loading concrete mixer manufacturers, which controls nearly 75 percent of India's market share. It is believed that the management team of this company is excellent and it may see growth in the coming times. Brokerage firm JM Financial has started covering this company at a target price of Rs 770. Along with this, it has been advised to buy it.

4- Apollo Hospitals Enterprises

Apollo Hospital Enterprises stock has gained more than 16%, brokerage firm JM Financial advised, saying that it is one of the largest integrated healthcare services companies in India. It has more than 6600 pharmacies, 267 clinics and 51 hospitals. 

5-OneSource Specialty Pharma

OneSource Specialty Pharma's stock is expected to rise by about 29 percent. Brokerage firm DAM Capital has estimated its revenue to grow by 33 percent on an annual basis between financial years 2025 and 2028. Its stock has been recommended to buy at a target price of Rs 2529.

Read More: Q1 Results: Company's earnings jump by Rs 4,670 crore but stock falls by more than 7%